Search

Your search keyword '"Thuillez, C."' showing total 386 results

Search Constraints

Start Over You searched for: Author "Thuillez, C." Remove constraint Author: "Thuillez, C."
386 results on '"Thuillez, C."'

Search Results

351. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].

352. Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.

353. A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers.

354. [Calcium inhibitors and myocardial ischemia].

355. Regional hemodynamic effects of perindopril in congestive heart failure.

356. [Systemic and regional hemodynamic effects of a new angiotensin converting enzyme and neutral endopeptidase mixed inhibitor, alatriopril, in the dog].

357. [Mechanical adaptation of muscular arteries to acute increase of blood pressure in man. Contribution of the measurement of arterial wall thickness].

359. [Calcium inhibitors. Principles and rules of use].

360. Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.

361. Use of ultrasonic and microsphere techniques to evaluate regional aspects of vasodilator therapy in myocardial ischaemia, arterial hypertension and heart failure.

362. Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.

363. Systemic and regional hemodynamic effects of zabicipril in healthy volunteers.

364. [Endothelin. A new class of vasoactive peptides].

366. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.

367. [Mechanisms and consequences of changes of the vasomotor activity in cardiac insufficiency].

368. Non invasive study of systemic and regional haemodynamic and cardiac effects of a new calcium antagonist, SR 33557, in healthy volunteers.

369. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].

370. [Modeling of the relation between plasma concentration of the active metabolite of perindopril and inhibition of the activity of plasma converting enzyme in healthy volunteers].

371. Systemic and regional hemodynamic effects of perindopril in congestive heart failure.

372. [The humeral artery and clinical pharmacology].

373. [Peripheral hemodynamic and biological effects of perindopril in the healthy subject. Dose-effect relationship].

374. Cimetidine does not alter free unchanged captopril pharmacokinetics and biological effects in healthy volunteer.

376. [Non-invasive regional and cardiac output determination in healthy volunteers. Predictive value].

377. Beta-adrenoceptor blocking effects and plasma levels of bornaprolol and propranolol in man.

378. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.

379. Theophylline kinetics and ventilatory flow in bronchial asthma and chronic airflow obstruction: influence of erythromycin.

380. Relationship between mixed venous oxygen saturation and cardiac index in patients with chronic congestive heart failure.

381. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.

382. Attenuation by diltiazem of arterial baroreflex sensitivity in man.

384. Effects of propranolol on regional myocardial blood flow and function during severe coronary stenosis in dogs.

385. [Pharmacological basis for the therapeutic use of calcium inhibitors. Part 1].

386. [Clinical pharmacology of converting enzyme inhibitors].

Catalog

Books, media, physical & digital resources